The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® …
KM Beeh, E Derom, J Echave-Sustaeta… - … obstructive pulmonary …, 2016 - Taylor & Francis
… A short-acting anticholinergic (ipratropium bromide) was provided for use during the … While
tiotropium + olodaterol has demonstrated clinically significant improvements in symptoms and …
tiotropium + olodaterol has demonstrated clinically significant improvements in symptoms and …
Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease. A systematic review
BR Celli, JA Anderson, NJ Cowans, C Crim… - … journal of respiratory …, 2021 - atsjournals.org
… criteria: COPD diagnosis, decline in lung function/FEV 1 , and … components, one fluticasone
propionate/salmeterol and the … acetylcysteine, and one used ipratropium bromide. All studies …
propionate/salmeterol and the … acetylcysteine, and one used ipratropium bromide. All studies …
The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized …
K Huang, Y Guo, J Kang, L An… - … in Respiratory …, 2019 - journals.sagepub.com
… of treatment with inhaled fluticasone, but no statistically … rapidly improved lung function,
health status, morning symptoms … with significant improvements in lung function, predose FEV …
health status, morning symptoms … with significant improvements in lung function, predose FEV …
Economic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies
MH Roberts, ME Borrego, AA Kharat… - Expert Review of …, 2016 - Taylor & Francis
… Noting that improvement in lung function was similar … for ipratropium, tiotropium, and
anticholinergics (ipratropium or … of symptoms, exacerbation experience, and lung function, but the …
anticholinergics (ipratropium or … of symptoms, exacerbation experience, and lung function, but the …
The Efficacy, Tolerance and Acceptance of a New Fixed-Dose Salmeterol and Fluticasone Propionate Dry-Powder Inhaler—Salflumix Easyhaler® in COPD Patients …
Z Doniec, M Olszanecka-Glinianowicz, P Hantulik… - Applied Sciences, 2022 - mdpi.com
… as partially preventable causes of accelerated lung aging in … This study showed a trend
towards improved survival in … ® ), including anticholinergics (ipratropium bromide or tiotropium …
towards improved survival in … ® ), including anticholinergics (ipratropium bromide or tiotropium …
[HTML][HTML] Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with …
SY Lee, JS Lee, SW Lee, YM Oh - Journal of Thoracic Disease, 2021 - ncbi.nlm.nih.gov
… symptoms, but empirical evidence supporting such practice is sparse. We evaluated the effect
of LAMA and LABA on lung function improvement … salbutamol and ipratropium inhalation …
of LAMA and LABA on lung function improvement … salbutamol and ipratropium inhalation …
Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
MIA Aziz, LE Tan, DBC Wu, F Pearce… - … obstructive pulmonary …, 2018 - Taylor & Francis
… obstruction with accompanying respiratory symptoms such as … [BudeForm]) and SAMA (ipratropium
40 mcg four times a day [… With regards to lung function, our results showed that LAMAs…
40 mcg four times a day [… With regards to lung function, our results showed that LAMAs…
Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management
V Backer, A Ellery, S Borzova, S Lane… - … in Respiratory …, 2018 - journals.sagepub.com
… of ICS, 12–16 and this strategy improves symptoms and lung function with a reduced risk of
… inhaler may also be associated with improved patient adherence relative to the treatments …
… inhaler may also be associated with improved patient adherence relative to the treatments …
Long-term fluticasone propionate/formoterol fumarate combination therapy is associated with a low incidence of severe asthma exacerbations
A Papi, AH Mansur, T Pertseva, K Kaiser… - … and pulmonary drug …, 2016 - liebertpub.com
… /formoterol Study 1, which mandated uncontrolled symptoms at … lung function ranged from
76% to 87% predicted FEV 1 . Thus the degree of lung function impairment in the fluticasone/…
76% to 87% predicted FEV 1 . Thus the degree of lung function impairment in the fluticasone/…
[HTML][HTML] Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: the 6-month …
GT Ferguson, DP Tashkin, T Skärby, C Jorup… - Respiratory …, 2017 - Elsevier
… (patients on a stable ipratropium dose were allowed to … symptoms or 1 major symptom in
combination with ≥1 minor … reduces exacerbations and improves lung function in patients with …
combination with ≥1 minor … reduces exacerbations and improves lung function in patients with …